A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With InhibitorMohammad Faranoush, Majid Naderi, Ramin Heshmat et al.|Clinical and Applied Thrombosis/Hemostasis|2014Cited by 22
A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII DeficiencyMohammad Faranoush, Majid Naderi, Minoo Ahmadinejad et al.|Clinical and Applied Thrombosis/Hemostasis|2014Cited by 17